In situ electrolyte interactions in a disk-compressed configuration system for up-curving and constant drug delivery

Journal of Controlled Release

Volumn 67, Issue 1, 2000, Pages 55-65

  Pillay, Viness ^a   Fassihi, Reza ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Chronotherapeutics; Disk compression technology; Lag time induction; Up curving and or zero order release

Indexed keywords

ADIPIC ACID; DEOXYCHOLATE SODIUM; DILTIAZEM; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; THEOPHYLLINE;

ARTICLE; DISSOLUTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; PRIORITY JOURNAL; TABLET COMPRESSION; TECHNOLOGY;

DILTIAZEM; DRUG DELIVERY SYSTEMS; ELECTROLYTES; HYDROGEN-ION CONCENTRATION; KINETICS; METHYLCELLULOSE; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; SOLUBILITY; TABLETS, ENTERIC-COATED; THEOPHYLLINE;

EID: 0034659661     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00192-9     Document Type: Article

References (26)

1. 2-blockers and cardiovascular active drugs. Adv. Drug Del. Rev. 6:1991;83-100.
2. Lemmer B., Nold N. Circadian changes in estimated hepatic blood flow in healthy subjects. Br. J. Clin. Pharmacol. 32:1991;627-629.
3. Lemmer B., Bruguerolle B. Chronopharmacokinetics: are they clinically effective? Clin. Pharmacokinet. 26:1994;419-427.
4. White W.B., Anders R.J., MacIntyre J.M., Black H.R., Sica D.S. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am. J. Cardiol. 76:1995;375-380.
5. White W.B. A chronotherapeutic approach to the management of hypertension. Am. J. Hypertens. 9:1996;29S-33S.
6. Ritschel W.A., Hwang S.T., Sabouni A., Govind R., Fassihi A.R. Hydrogel piston pump drug delivery system: a novel approach. Pharm. Res. 9:1992;S250.
7. McClelland G.A., Sutton S.C., Engle K., Zentner G.M. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride. Pharm. Res. 8:1991;88-92.
8. Fassihi R.A., Ritschel W.A. Multiple-layer, direct-compression, controlled release system: in vitro and in vivo evaluation. J. Pharm. Sci. 82:1993;750-754.
9. U. Conte, A. La Manna, L. Maggi, Controlled Release Pharmaceutical Tablet Having Lenticular Form, US Patent 5,626,874, May 6, 1997.
10. T. Hayashida, K. Kikumaru, O. Tomoyuki, Sustained Release Tablet, US Patent 5,593,694, January 14, 1997.
11. Kim H., Fassihi R. Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism. J. Pharm. Sci. 86:1997;316-322.
12. R. Fassihi, L. Yang, Controlled Release Drug Delivery System, US Patent 5,783,212, July 21, 1998.
13. Pillay V., Fassihi R. Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. J. Pharm. Sci. 88:1999;1140-1148.
14. Ramtoola Z., Corrigan O.I. Influence of buffering capacity of the medium on the dissolution of drug-excipient mixtures. Drug Dev. Ind. Pharm. 15:1989;2359-2374.
15. Doherty C., York P. Microenvironmental pH control of drug dissolution. Int. J. Pharm. 50:1989;223-232.
16. Mooney K.G., Mintun M.A., Himmelstein K.J., Stella V.J. Dissolution kinetics of carboxylic acids II: effect of buffers. J. Pharm. Sci. 70:1981;22-32.
17. J.J. Michelucci, D.M. Sherman, Sustained Release Etodoloc, US Patent 4,966,768, October 30, 1990.
18. Chakrabarthi S., Southard M.Z. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow 2. Cocompression of drugs with buffers. J. Pharm. Sci. 86:1997;465-469.
19. Pagay S.N. Use of buffers in matrix capsule formulations. Drug Dev. Ind. Pharm. 14:1988;875-894.
20. Venkatesh G.M. Development of controlled release SK&F 82526-J buffer bead formulations with tartaric acid as the buffer. Pharm. Dev. Tech. 3:1998;477-485.
21. G.A. McClelland, G.M. Zentner, Swelling Modulated Polymeric Drug Delivery Device, US Patent 5,120,548, June 9, 1992.
22. Thoma K., Zimmer T. Retardation of weakly basic drugs with diffusion tablets. Int. J. Pharm. 58:1990;197-202.
23. Gabr K.E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm. 38:1992;199-202.
24. V. Pillay, R. Fassihi, Monolithic Tablet for Controlled Drug Release, US Patent Application Filed, Serial number 09/037,096, 1998.
25. Yang L., Johnson B., Fassihi R. Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and hpmc tablets undergoing hydration: a texture analysis study. Pharm. Res. 15:1998;1902-1906.
26. Schott H. Colloidal dispersions. Gennaro A.R. 19th Edition Remington: The Science and Practice of Pharmacy. Vol. 1:1995;252-277 Mack Publishing, Easton, PA.